Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Friedman

Showing results (1441-1450 of 1,475) with videos related to

Pageof 148
Sort By:
Neuroscience and Biobehavioral Reviews|May 25, 2019
Physiological feelingsEdward F Pace-Schott, Marlissa C Amole, Tatjana Aue, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 3, 2006
Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial resultsDavid A Reardon, Jennifer A Quinn, Gamal Akabani, et al.
Journal of Neuro-Oncology|December 3, 2003
Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumorsJohn H Sampson, Gamal Akabani, Gary E Archer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant gliomaJennifer A Quinn, Annick Desjardins, Jon Weingart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiformeDavid A Reardon, Merrill J Egorin, Jennifer A Quinn, et al.
Journal of Neural Engineering|May 19, 2021
Flexible, high-resolution thin-film electrodes for human and animal neural researchChia-Han Chiang, Charles Wang, Katrina Barth, et al.
Briefings in Bioinformatics|November 22, 2018
Harmonizing semantic annotations for computational models in biologyMaxwell Lewis Neal, Matthias König, David Nickerson, et al.
Nature Communications|May 27, 2018
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastomaBill H Diplas, Xujun He, Jacqueline A Brosnan-Cashman, et al.
Journal of Neurosurgery|April 4, 2025
Intraoperative brain tumor classification via laser-induced fluorescence spectroscopy and machine learningTanner J Zachem, Jacob E Sperber, Sully F Chen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 2026
Longitudinal Dynamics of Polyglutamine-Expanded ATXN3 in Biofluids of Spinocerebellar Ataxia Type 3Jordan Bartfield, Lukasz Milanowski, Karen R Jansen-West, et al.
Pageof 148

Showing results (1441-1450 of 1,475) with videos related to

Sort By:
Pageof 148
Neuroscience and Biobehavioral Reviews|May 25, 2019
Physiological feelingsEdward F Pace-Schott, Marlissa C Amole, Tatjana Aue, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 3, 2006
Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial resultsDavid A Reardon, Jennifer A Quinn, Gamal Akabani, et al.
Journal of Neuro-Oncology|December 3, 2003
Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumorsJohn H Sampson, Gamal Akabani, Gary E Archer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant gliomaJennifer A Quinn, Annick Desjardins, Jon Weingart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiformeDavid A Reardon, Merrill J Egorin, Jennifer A Quinn, et al.
Journal of Neural Engineering|May 19, 2021
Flexible, high-resolution thin-film electrodes for human and animal neural researchChia-Han Chiang, Charles Wang, Katrina Barth, et al.
Briefings in Bioinformatics|November 22, 2018
Harmonizing semantic annotations for computational models in biologyMaxwell Lewis Neal, Matthias König, David Nickerson, et al.
Nature Communications|May 27, 2018
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastomaBill H Diplas, Xujun He, Jacqueline A Brosnan-Cashman, et al.
Journal of Neurosurgery|April 4, 2025
Intraoperative brain tumor classification via laser-induced fluorescence spectroscopy and machine learningTanner J Zachem, Jacob E Sperber, Sully F Chen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 2026
Longitudinal Dynamics of Polyglutamine-Expanded ATXN3 in Biofluids of Spinocerebellar Ataxia Type 3Jordan Bartfield, Lukasz Milanowski, Karen R Jansen-West, et al.
Pageof 148